Type : Bid Notification
An important strategic goal of the Administration for Strategic Preparedness and Response (ASPR) Biomedical Advanced Research and Development Authority (BARDA) and Defense Production Act (DPA) Title III Program is to support and facilitate development of the technological infrastructure within the domestic pharmaceutical manufacturing industry to provide new materials, products, capabilities, and manufacturing paradigms for the Nation. Specifically, ASPR, BARDA, and DPA Title III are seeking to expand domestic sterilization capacity to enable U.S. suppliers to support the production of 600 million vaccine doses within six to nine months with minimal disruption to the baseline public health supply chain. This increased capacity will support ...